Can a prefilled pen match a syringe for this biosimilar?

NCT ID NCT07744828

Not yet recruiting Knowledge-focused Sponsor: Dr. Reddy's Laboratories Limited Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study compares two ways of giving the same experimental biosimilar drug, DRL_AB, which is designed to work like abatacept for autoimmune conditions. Healthy male volunteers receive a single dose either through an autoinjector or a prefilled syringe. Researchers measure how much drug reaches the blood and how the body handles it, to see if both devices deliver the medicine equally well and safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DRL_AB, a proposed biosimilar of abatacept, given as a subcutaneous injection
What this could lead to: If the two injection methods deliver the drug similarly, it could support a more convenient autoinjector option for patients who need abatacept.
What could go wrong: This is an early-stage study in healthy volunteers, not patients, so results may not predict real-world effectiveness. Injection-site reactions or other side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease arthropathy juvenile idiopathic arthritis psoriatic arthritis rheumatic disorder rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Locations

Momentum Clinical Research

Auckland, New Zealand
New Zealand Clinical Research

Auckland, New Zealand
New Zealand Clinical Research

Christchurch, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.